Andere Kunden interessierten sich auch für
![Predictive Admet]( "Predictive Admet")
Predictive Admet180,99 €![Drug Delivery Applications of Noninvasive Imaging]( "Drug Delivery Applications of Noninvasive Imaging")
Drug Delivery Applications of Noninvasive Imaging205,99 €![Mass Spectrometry for Drug Discovery and Drug Development]( "Mass Spectrometry for Drug Discovery and Drug Development")
Mass Spectrometry for Drug Discovery and Drug Development154,99 €![Flow Cytometry]( "Flow Cytometry")
Flow Cytometry164,99 €![Absorption 2e]( "Absorption 2e")
Absorption 2e191,99 €![Production of Plasma Proteins for Therapeutic Use]( "Production of Plasma Proteins for Therapeutic Use")
Production of Plasma Proteins for Therapeutic Use183,99 €![Emerging Technology Platforms for Stem Cells]( "Emerging Technology Platforms for Stem Cells")
Emerging Technology Platforms for Stem Cells186,99 €
Enables researchers to better detect, measure, and characterize aggregates and particles during protein drug development
Featuring contributions from leading pharmaceutical investigators around the world, this text enables researchers to choose the most appropriate analytical methods in order to detect and characterize the full spectrum of protein aggregates and particles that can be present in a protein pharmaceutical. Moreover, the authors provide detailed examples of how these methods can be applied during both process and formulation development, helping researchers better manage the problem of protein instability as they seek to develop protein drugs.
The text begins with an introduction to aggregates and particles, focusing on their potential immunogenicity. Next, it covers:
Methods to detect and measure soluble aggregates based on separation, light scattering, and new technology
Methods to detect and measure insoluble aggregates and both sub-visible and visible particles
Spectroscopic techniques such as UV/VIS, fluorescence, infrared and Raman spectroscopy, and microscopy to characterize aggregates and particles, elucidate their structures, and identify proteinaceous and non-proteinaceous particles
Comparative advantages and disadvantages of the methods for protein aggregate analysis
Approaches for managing aggregates and particles found during protein purification and formulation development
Throughout the text, case studies help researchers deal with the challenges that arise in detecting and analyzing protein aggregates and particles.
Protein pharmaceuticals are increasingly used to treat life-threatening and chronic diseases, including cancer, viral infections, metabolic disorders, and central nervous system diseases. With Analysis of Aggregates and Particles in Protein Pharmaceuticals as their guide, pharmaceutical researchers now have an important tool in overcoming the challenging problem of aggregates and particles in protein drug development. This book describes how to address the analysis of aggregates and particles in protein pharmaceuticals, provides a comprehensive overview of current methods and integrated approaches used to quantify and characterize aggregates and particles, and discusses regulatory requirements. Analytical methods covered in the book include separation, light scattering, microscopy, and spectroscopy.
Featuring contributions from leading pharmaceutical investigators around the world, this text enables researchers to choose the most appropriate analytical methods in order to detect and characterize the full spectrum of protein aggregates and particles that can be present in a protein pharmaceutical. Moreover, the authors provide detailed examples of how these methods can be applied during both process and formulation development, helping researchers better manage the problem of protein instability as they seek to develop protein drugs.
The text begins with an introduction to aggregates and particles, focusing on their potential immunogenicity. Next, it covers:
Methods to detect and measure soluble aggregates based on separation, light scattering, and new technology
Methods to detect and measure insoluble aggregates and both sub-visible and visible particles
Spectroscopic techniques such as UV/VIS, fluorescence, infrared and Raman spectroscopy, and microscopy to characterize aggregates and particles, elucidate their structures, and identify proteinaceous and non-proteinaceous particles
Comparative advantages and disadvantages of the methods for protein aggregate analysis
Approaches for managing aggregates and particles found during protein purification and formulation development
Throughout the text, case studies help researchers deal with the challenges that arise in detecting and analyzing protein aggregates and particles.
Protein pharmaceuticals are increasingly used to treat life-threatening and chronic diseases, including cancer, viral infections, metabolic disorders, and central nervous system diseases. With Analysis of Aggregates and Particles in Protein Pharmaceuticals as their guide, pharmaceutical researchers now have an important tool in overcoming the challenging problem of aggregates and particles in protein drug development. This book describes how to address the analysis of aggregates and particles in protein pharmaceuticals, provides a comprehensive overview of current methods and integrated approaches used to quantify and characterize aggregates and particles, and discusses regulatory requirements. Analytical methods covered in the book include separation, light scattering, microscopy, and spectroscopy.